Adial Pharmaceuticals, Inc
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Adial Pharmaceuticals, Inc now
Current reporting with the operating signal separated from the noise.
Adial Pharmaceuticals, Inc. total assets 2021-2025
The story matters when it changes Adial Pharmaceuticals, Inc’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.All You Need to Know About Adial Pharmaceuticals, Inc. (ADIL) Rating Upgrade to Buy
The story matters when it changes Adial Pharmaceuticals, Inc’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Cours Adial Pharmaceuticals, Inc.
The story matters when it changes Adial Pharmaceuticals, Inc’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest ADIL filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Adial Pharmaceuticals, Inc, quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →